Specifically, dual NMDA-P2RX7 compounds were recently synthesized for targeting both the excitotoxicity-induced cell death as well as the P2RX7-dependent neuroinflammatory-induced cell death seen in Alzheimer's disease (Karoutzou et al., 2018). Here, P2RX7 is linked to early-onset autosomal dominant Alzheimer disease.